Chief Investigators: Fahey, Novak, Finch-Edmundson. CP Alliance (2019-22) $250k.
Aims: National harmonised datasets to (i) review history, deep clinical and MRI phenotypes in a Vietnamese cohort of CP who have already received autologous MSCs; (ii) undertake genotyping; and (iii) use machine learning to examine the relationship between the genotype, MRI, phenotypic and response to stem cell therapy.
New Knowledge: Progress understanding of genomics, MRI biomarkers and stem cell therapies establishing best-responders & non-responders, enabling cheaper, powered trials.
